Our MyoRICAT instrument comprises a suite of computerised adaptive tests (CATs) that measures the impact of myopia interventions (e.g. glasses, contact lenses and laser surgeries) on five domains of quality of life.

With a user-friendly interface and automated feedback system, MyoRICAT offers researchers, clinicians and clinical trial teams a precise and efficient PROM to evaluate the effectiveness of treatments and interventions, including spectacles, contact lenses, and refractive surgery such as LASIK and SMILE, from the patient’s perspective.

MyoRICAT has been developed and validated in patients with undergoing different myopia treatments and interventions in Singapore and is currently available for use.